Caplight Awarded Patent for AI-Powered Pricing Feed To Improve Private Market Transparency
SAN FRANCISCO, May 6, 2025 /PRNewswire/ -- Caplight Technologies, an innovator in private market data and trading infrastructure, today announced the issuance of a patent by the United States Patent and Trademark Office protecting Caplight's proprietary method for estimating private company stock prices using secondary market transaction data.
Caplight private company estimated pricing visualization.
U.S. Patent No. 12,243,130 B2, titled "Data Interpolation Platform for Generating Predictive and Interpolated Pricing Data," grants Caplight exclusive rights to a proprietary method for estimating private company prices and valuations that includes aggregating private market data, generating price estimates, and visualizing them through an interactive interface.
The patented technology powers Caplight MarketPriceTM and is used by private company investors, shareholders, and brokers to understand market-clearing price levels. "Lack of liquidity is one of the biggest challenges the venture capital ecosystem faces today. Accurate and timely pricing data is necessary for venture capital investors to make better-informed liquidity decisions," said Javier Avalos, Co-Founder and Chief Executive Officer.
The issuance of this patent underscores Caplight's commitment to advancing private markets through technology innovation. "We're proud to be on the cutting edge of making venture capital more liquid. The technology covered by this patent removes an information asymmetry that prevented participants from accessing the secondary market previously," said Justin Moore, Co-founder and Chief Technology Officer.
About Caplight
Caplight Technologies, Inc. is a financial technology company providing data and liquidity solutions to the private market. The company's price discovery tools enable market participants to navigate venture capital with more confidence. Securities are offered through Caplight Markets LLC, member FINRA/SIPC, a wholly-owned subsidiary of Caplight Technologies, Inc.
For inquiries, contact: contact@caplight.com
Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/caplight-awarded-patent-for-ai-powered-pricing-feed-to-improve-private-market-transparency-302448003.html
SOURCE Caplight
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Diagnostic Electrocardiograph/ECG Market worth US$15.18 billion by 2032 with 7.4% CAGR
DELRAY BEACH, Fla., June 13, 2025 /PRNewswire/ -- The global Diagnostic Electrocardiograph/ECG Market, valued at US$8.59 billion in 2024 stood at US$9.19 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2032, culminating in a forecasted valuation of US$15.18 billion by the end of the period. The growth in the ECG diagnostic market can be attributed to several critical factors. The rising prevalence of chronic conditions, particularly CVDs, is a significant driver. Additionally, there is a marked shift towards home healthcare solutions, propelled by advancements in wearable technology and the broader digital transformation within the healthcare sector. The burgeoning geriatric demographic, which is increasingly susceptible to cardiac disorders, further amplifies the demand for ECG diagnostics across various healthcare environments. Technological innovations, specifically the advent of portable ECG devices and AI-enhanced ECG interpretation, are enhancing diagnostic precision and improving patient accessibility. Moreover, government initiatives aimed at promoting cardiac health, coupled with a growing acceptance of point-of-care diagnostic methodologies, are anticipated to bolster market growth moving forward. Download PDF Brochure: Browse in-depth TOC on "Diagnostic Electrocardiograph/ECG Market" 150 - Tables60 - Figures250 - Pages By Product, the diagnostic ECG market is categorized into diagnostic ECG devices and diagnostic ECG software & services, with the diagnostic ECG devices segment commanding the largest market share. This predominance is attributable to the critical role these devices play in routine cardiac diagnostics, the swift identification of arrhythmias, and long-term cardiac monitoring. Standard resting ECGs serve as fundamental assessments in both primary care and specialized medical environments, while Holter monitors facilitate extensive and continuous cardiac surveillance over extended periods. The demand for these diagnostic tools is significantly influenced by the rising geriatric population, which correlates with an increase in CVD prevalence within this demographic. According to WHO, over 80% of CVD-related fatalities result from heart attacks and strokes, with one-third of these deaths occurring prematurely in individuals under 70 years of age; this statistic underscores the urgent need for effective cardiac monitoring solutions in the face of growing cardiovascular health challenges. By lead type, the diagnostic ECG market is categorized based on lead types into 12-lead, 5-lead, 3-lead, 6-lead, and single-lead ECG devices. Notably, 12-lead ECG systems dominate the market due to their superior diagnostic capabilities, allowing for precise measurement of cardiac electrical activity. Regarded as the gold standard for the advanced diagnosis of cardiac pathologies, including myocardial infarctions and arrhythmias, these systems are widely endorsed by clinical guidelines for use in hospitals and cardiology clinics. Their approval for emergency and critical care applications further cements their market leadership. Key manufacturers of 12-lead diagnostic ECG devices include Koninklijke Philips N.V. (Netherlands), ACS Diagnostics (US), OSI Systems, Inc. (US), and GE Healthcare (US). By type, the diagnostic ECG market is further segmented into portable, wearable, and implantable ECG devices. In 2024, the portable ECG devices segment accounted for the largest market share, driven by their convenience, mobility, and diverse applications in both clinical settings and home care. Unlike traditional ECG machines, which are typically bulkier and stationary, portable devices enable on-demand or continuous cardiac monitoring from virtually any location. A significant advantage of these devices is their ability to wirelessly record and transmit ECG data to healthcare providers, facilitating remote patient monitoring. This capability not only allows for timely interventions but also minimizes the need for frequent hospital visits, which is particularly beneficial for patients with chronic heart conditions. As a result, the emphasis on remote patient care and the demand for personalized healthcare solutions are the primary factors propelling the growth of portable ECG devices, solidifying their dominant position within the diagnostic ECG market. By end user, the diagnostic ECG market is segmented into hospitals, primary care centers, cardiac centers, ambulatory surgery centers, urgent care settings, and home care settings. The hospitals segment held the largest market share primarily due to the high volume of cardiovascular patient admissions and the presence of state-of-the-art diagnostic infrastructure. The integration of ECG systems with other cardiac diagnostic modalities enhances their utility in both inpatient and outpatient settings, especially within emergency and ICUs. The increasing rates of hospital admissions for cardiac conditions, combined with the emphasis on early detection and timely intervention, position hospitals as the predominant end users of ECG technologies; this trend is a key driver of overall market expansion in the diagnostic ECG market. By geography, the diagnostic ECG market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The North American market has successfully secured a substantial share, driven by several key factors. One major contributor is the growth in the geriatric population, which is leading to an increased demand for healthcare services and diagnostic tools. Alongside this demographic shift, there has been a notable rise in the prevalence of chronic diseases, such as CVDs and diabetes, that require regular monitoring and management through advanced diagnostic ECG solutions. Additionally, the enhancement of healthcare infrastructure in the region plays a crucial role in facilitating better access to these diagnostic services. Hospitals & clinics are increasingly equipped with state-of-the-art technology and resources, enabling healthcare providers to offer timely and effective care. Furthermore, supportive government initiatives aimed at improving healthcare accessibility also have a positive impact on the market. Policies designed to reduce barriers to healthcare services and promote innovative diagnostic technologies are helping to ensure that patients can receive necessary care without significant obstacles. The strategic expansion of key players in the North American market, which includes both established companies and emerging startups, is anticipated to further bolster market growth. The active presence of these industry leaders not only enhances competition but also drives innovation in product development, ultimately benefiting patients and healthcare providers alike. Overall, these factors collectively signify a robust growth trajectory for the ECG diagnostic solutions market in North America. Request Sample Pages : As of 2024, diagnostic ECG market was dominated by GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Baxter (US), FUKUDA DENSHI (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), NIHON KOHDEN CORPORATION (Japan), OSI Systems, Inc. (US), Bittium (Finland), iRhythm Technologies, Inc. (US), Lepu Medical Technology (Beijing) Co., Ltd. (China), Midmark Corporation (US), BPL Medical Technologies (India), SCHILLER (Switzerland), ACS Diagnostics (US), Allengers (India), and Bionet Co., Ltd. (South Korea), among others. GE Healthcare (US): GE Healthcare is a well-established entity in the diagnostic ECG sector, boasting over 125 years of industry experience and a formidable reputation within the global healthcare landscape. The company effectively utilizes its extensive global footprint in medical technology, diagnostics, and digital solutions, catering to a diverse clientele across 160 countries while adhering to sustainable operational practices. Central to GE Healthcare's strategy is a robust emphasis on R&D to optimize existing offerings and innovate new products and services. This commitment allows the company to stay responsive to evolving customer demands and to capitalize on emerging market opportunities. In a notable move for 2024, GE Healthcare invested approximately USD 969 million to enhance manufacturing capabilities and local R&D initiatives in India over the next five years. The company's growth strategy encompasses a range of collaborations, agreements, expansions, and acquisitions to strengthen its operational reach and market presence. These strategic endeavors not only expand the product portfolio but also fortify the company's competitive standing in the market. In a recent development, GE Healthcare partnered with the Mayo Clinic in September 2023 to leverage advanced technologies and improve the precision of diagnostics and treatment processes for healthcare providers. Koninklijke Philips N.V. (Netherlands) Koninklijke Philips N.V. (Royal Philips) serves as the parent organization of the Philips Group, strategically operating across four core domains: Personal Health, Diagnosis & Treatment, Connected Care, and Others. Within the Connected Care segment, Philips provides advanced diagnostic solutions, including cardiographs, Holter monitoring systems, and stress-testing ECGs. The company's growth strategy is heavily centered on forming strategic partnerships in high-potential markets and fostering collaborative efforts to drive innovation. A notable example of this approach is the 2023 partnership with NYU Langone Health to leverage innovative technologies and enhance patient care over an eight-year span. Additionally, in January 2025, Philips is set to present its latest innovations at Arab Health 2025. These advancements emphasize the integration of smart systems, automation, and cloud-based informatics into healthcare delivery, targeting reductions in clinician workload and improvements in operational workflows, ultimately leading to enhanced patient outcomes. Key subsidiaries within the Philips ecosystem include Philips Oral Healthcare, LLC (US), Philips GmbH (Germany), Philips Ultrasound, Inc. (US), and Philips Consumer Lifestyle B.V. (Netherlands). The company maintains a comprehensive operational footprint across North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Shenzhen Mindray Bio-Medical Electronics Co. (China) Shenzhen Mindray Bio-Medical Electronics is a prominent entity in the diagnostic ECG segment, distinguished by its diverse operational structure across three primary business verticals: Patient Monitoring and Life Support, In-vitro Diagnostics, and Medical Imaging Systems. Within the Patient Monitoring & Life Support sector, the company delineates its offerings into Patient Monitoring Systems, ECG devices, and ancillary products. Mindray dedicates more than 10% of its revenue to R&D, which underpins its commitment to innovation and sustains a formidable portfolio of over 3,000 patents. This investment not only fuels technological advancement but also strengthens its competitive edge. The company has also established strategic partnerships to enhance its market penetration and product offerings. Notably, its collaboration with Amazon Business facilitates improved access to medical equipment for healthcare systems, hospitals, and practitioners, streamlining procurement and distribution channels in a rapidly evolving healthcare landscape. For more information, Inquire Now! Related Reports: Cardiac Monitoring & Cardiac Rhythm Management Devices Market Patient Monitoring Devices Market Brain Monitoring Market Patient Temperature Monitoring Market MRI Systems Market Get access to the latest updates on Diagnostic Electrocardiograph/ECG Companies and Diagnostic Electrocardiograph/ECG Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content to download multimedia: SOURCE MarketsandMarkets
Yahoo
20 minutes ago
- Yahoo
Kathy Bloomgarden Wins PR Agency Leader at Campaign Agency of the Year Global Awards
NEW YORK, June 13, 2025 /PRNewswire/ -- Dr. Kathy Bloomgarden, CEO of Ruder Finn, was awarded Agency Leader in the PR, Marketing, and Communications category at this year's Campaign Agency of the Year Global Awards. Campaign Global recognized Bloomgarden for her leadership in emerging technologies and artificial intelligence driven communications, and for driving 8% growth for the agency in 2024, contributing to a remarkable 140% increase over the past five years. Bloomgarden has been at the helm of Ruder Finn as CEO since 2014. Under her leadership, Ruder Finn has reached many new frontiers, including launching the agency's China office, healthcare practice, and technology innovation hub Bloomgarden has driven industry-leading growth and global expansion, pioneering the adoption of disruptive technologies. She has been at the forefront of AI strategies, shaping AI-ready data infrastructures, addressing LLM hallucinations, and bridging east-west divides in AI development. Within the past year, Bloomgarden established the RF AI Advisory Council and spearheaded the agency's newest LLM optimization offering She convenes high-level dialogues on tech disruption and is a trusted voice in global leadership circles, including the World Economic Forum and Fortune's CEO Council. With her ability to anticipate trends and act decisively, Bloomgarden has made Ruder Finn a key partner for global clients navigating economic uncertainties, geopolitical tension, and technological disruption. "It is an honor to receive this prestigious honor from Campaign Global," said Bloomgarden. "We are at a transformative juncture for our industry, where the role of communications is crucial in driving the adoption of groundbreaking technologies on a global scale across industries. I am profoundly optimistic about our collective ability to work together, and for communications change-makers to fast-track innovation and create significant change." This year's Campaign Agency of the Year Global Awards were held in London on June 12th, 2025. About Ruder Finn Ruder Finn is one of the world's largest independent global communications and integrated marketing agencies, leading the industry in AI strategy and implementation. Founded in 1948, Ruder Finn has defined and redefined PR for over 75 years, shaping communications that moves industry-defining brands, companies, and leaders from what's now to what's next. Ruder Finn provides clients with bold strategies based on a global perspective and localized market knowledge that redefine leadership, reimagine the marketplace, and rethink customer experiences. The agency is organized around five core areas of expertise—Healthcare, Technology, Consumer Brand, Leadership and Workplace—with innovative tech incubator RF TechLab providing cutting-edge predictive analytics, AI-powered creative hub RF Studio53 offering breakthrough creative, and specialized teams delivering customer-focused digital engagement. Ruder Finn has offices across four continents including the U.S., Asia, Europe and the Middle East. Wholly owned agencies and offerings within Ruder Finn Group include: Ruder Finn Inc., RF Studio53, RF Engage, Touchdown, Peppercomm, RF Comunicad, Mantis, jacobstahl, Flightpath, Ruder Finn Atteline, Pandan Social, RF Bloom, and Big Sky Communications. For more information visit Media Contact: Isabelle Lee, View original content to download multimedia: SOURCE Ruder Finn Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27 minutes ago
- Yahoo
Hernest Launches Renata Collection: A Design-Centered Response to the Evolving Aesthetics of the Modern Home
NEW YORK, June 13, 2025 /PRNewswire/ -- Hernest, a fast-growing home furniture brand with an established warehousing and logistics footprint across the U.S., has officially launched the Renata Collection, a new series designed for homeowners seeking refined modern design grounded in natural materials and visual clarity. The Renata Collection represents Hernest's latest effort to address a growing demand for furniture that combines contemporary aesthetics with emotional resonance. The series includes a curated range of products, including a 71-inch sideboard, travertine-textured TV stand, coffee table, and nightstand—all characterized by woodgrain finishes, textural contrast, and proportion-driven silhouettes. Design Strategy: Balancing Retro Forms and Natural Tactility According to Hernest's internal design documentation, Renata was developed to expand the brand's retro-modern offering, with an emphasis on calming material palettes and simplified forms. Rather than introducing novelty, the design approach leans on established principles—symmetry, weight distribution, and visual texture—while drawing from mid-century and contemporary design vocabularies. Key pieces in the collection, such as the travertine-textured nightstand and TV console, integrate stone-inspired finishes with matte tones to achieve visual depth without compromising functional simplicity. Meanwhile, the Renata coffee table and Renata sideboards adopt softened corners and elevated bases, aligning with Hernest's broader strategy to design for emotional warmth rather than decorative excess. "The Renata Collection is a continuation of our intent to create furniture that reflects a grounded, nature-centered lifestyle," said a Hernest designer. "We're designing for customers who care about materiality and atmosphere—not just aesthetics. This collection is not static—we plan to introduce additional pieces over time to further complete the line and respond to evolving needs within the home." Infrastructure as Strategy: A Seven-Warehouse U.S. Network From a business operations perspective, Hernest's growing catalog is supported by a maturing logistics framework. The company currently operates seven regional warehouses—among Washington, California, New Jersey, Georgia, and Texas—enabling fulfillment from the facility closest to a customer's address. This setup reduces last-mile delivery time and minimizes the risk of product damage, allowing Hernest to offer quality shipping across the continental U.S. The company reports that over 90% of in-stock orders ship within two business days, and partnerships with multiple logistics providers enable streamlined in-home delivery coverage across 48 states. This distributed model has become a core part of Hernest's customer value proposition. Unlike many DTC furniture brands that rely heavily on centralized shipping or third-party fulfillment, Hernest's warehouse ownership allows for tighter control over inventory and service-level performance. Company Background: From Iteration to Market Differentiation Hernest's product development process has historically favored long iteration cycles over rapid trend response. The brand's first furniture design, launched in 2015 after 891 revisions, set the tone for a development model centered on durability, form consistency, and restrained styling. In 2017, the company introduced its first mid-century inspired line, following internal reflection on modern design's emotional and spatial qualities. This move led to a more defined brand identity—one centered not around maximal functionality or modularity, but around the sensory and atmospheric impact of materials such as wood veneer, travertine-textured panels, and matte finishes. Since 2020, people paid greater attention to furniture's role in long-term domestic life. By 2025, updated consumer behavior had reinforced Hernest's commitment to natural textures, retro-modern forms, and emotionally intelligent product narratives. Market Positioning: Design-Forward, Price-Accessible While Hernest does not position itself as a luxury brand, its pricing structure remains deliberately closer to designer-level aesthetics than to mass-market or budget-tier products. The brand targets homeowners and design-conscious consumers who prefer intentionality over volume—people building long-term spaces rather than furnishing short-term rentals or compact studios. "Our view is that design should be accessible, but not diluted," said the same designer. "Renata reflects that balance—thoughtful, quiet pieces, priced to be attainable without sacrificing finish quality." Outlook of the Furniture Market As the U.S. home furnishings market continues to fragment between low-cost imports and high-end designer offerings, brands like Hernest occupy a middle-ground position—offering style-forward collections supported by serious investment in domestic logistics and long-cycle design strategy. The Renata Collection reinforces this positioning and serves as a touchpoint for the brand's broader ambitions: to expand its presence in North America while retaining creative control over its product line and customer experience. View original content: SOURCE HERNEST Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
